Relieves and/or prevents cravings and nicotine withdrawal symptoms associated with tobacco dependence. It is indicated to aid smokers wishing to quit or reduce prior to q

Relieves and/or prevents cravings and nicotine withdrawal symptoms associated with tobacco dependence. It is indicated to aid smokers wishing to quit or reduce prior to quitting, to assist smokers who are unwilling or unable to smoke, and as a safer alternative to smoking for smokers and those around them. It is indicated in pregnant and lactating women making a quit attempt.

12 years and over: Use whenever the urge to smoke is felt or to prevent cravings in situations where these are likely to occur. Smokers willing or able to stop smoking im

12 years and over: Use whenever the urge to smoke is felt or to prevent cravings in situations where these are likely to occur. Smokers willing or able to stop smoking immediately should initially replace all their cigarettes with the Inhalator and as soon as they are able, reduce the number of cartridges used until they have stopped completely. Smokers aiming to reduce cigarettes should use the Inhalator, as needed, between smoking episodes to prolong smoke-free intervals and with the intention to reduce smoking as much as possible. As soon as they are ready smokers should aim to quit smoking completely. Maximum of 6 cartridges per day should be used. When making a quit attempt behavioural therapy, advice and support will normally improve the success rate. Those who have quit smoking, but are having difficulty discontinuing their Inhalator are recommended to contact their pharmacist or doctor for advice.

Relief of nicotine withdrawal symptoms as an aid to smoking cessation. It is used to help smokers ready to stop smoking immediately and also smokers who need to cut down

Relief of nicotine withdrawal symptoms as an aid to smoking cessation. It is used to help smokers ready to stop smoking immediately and also smokers who need to cut down their cigarette use before stopping. It is also indicated in pregnant and lactating women.

Over 18 years: The tablet is used sublingually with a recommended dose of one tablet per hour or, for heavy smokers (more than 20 cigarettes per day), two tablets per hou

Over 18 years: The tablet is used sublingually with a recommended dose of one tablet per hour or, for heavy smokers (more than 20 cigarettes per day), two tablets per hour. Most smokers require 8-12 or 16-24 tablets per day, not to exceed 40 tablets. Smoking cessation: Patients should stop smoking during treatment. Duration of treatment is individual but up to 3 months of treatment is recommended. The nicotine dose should then be gradually reduced by decreasing the total number of tablets used per day. Treatment should be stopped when daily consumption is down to one or two tablets. Those who use NRT beyond 9 months should consult a healthcare professional. Smoking reduction: The microtab should be used between smoking episodes to reduce smoking. A quit attempt should be made as soon as the smoker feels ready but no later than 6 months. Professional advice should be sought if no reduction in 6 weeks or no quit attempt in 9 months. Adolescents (12 to 18 years): No more than 40 tablets should be used each day. Smoking cessation: As adult dosage, but treatment should be used for up to 8 weeks before gradually reducing over 4 weeks. Treatment should be stopped when daily consumption is down to one or two tablets. If further treatment is required, a healthcare professional should be consulted. Smoking reduction: Only after consulting a healthcare professional.

Over 18 years: The patients should make every effort to stop smoking completely during treatment with Nicolette Nasal Spray. The frequency of use depends on the previous

Over 18 years: The patients should make every effort to stop smoking completely during treatment with Nicolette Nasal Spray. The frequency of use depends on the previous smoking habit of the individual and the level of their nicotine dependence. On commencing treatment, the patient uses the spray to treat craving as required, subject to a limit of one spray to each nostril twice an hour. The daily limit of use is 32mg of nicotine (64 sprays) which is the equivalent of two sprays to each nostril every hour for 16 hours. Use should be restricted to 3 months. For the first 8 weeks as required to a maximum of one spray into each nostril twice an hour for 16 hours per day. For the subsequent 2 weeks, reduce usage by half. Final 2 weeks, reduce usage to zero. Adults who use NRT beyond 9 months should seek advice from a healthcare professional. Adolescents (12 to 18 years): As adult dosage, but therapy should not exceed 12 weeks without consulting a healthcare professional.

Relief of and/or prevention of cravings and nicotine withdrawal symptoms associated with tobacco dependence. To aid smokers wishing to quit or reduce prior to quitting. T

Relief of and/or prevention of cravings and nicotine withdrawal symptoms associated with tobacco dependence. To aid smokers wishing to quit or reduce prior to quitting. To assist smokers who are unwilling or unable to smoke, and as a safer alternative to smoking for smokers and those around them. Can be used in pregnant and lactating women making a quit attempt. Should preferably be used in conjunction with a behavioural support programme.
For smokers of less than 20 cigarettes a day. For those smoking between 20-30 cigarettes a day either the 2mg or 4mg gum may be used depending on personal preference and characteristics.

Adults and adolescents (12-18 years): 1 piece to be chewed when the urge to smoke is felt following the chewing technique on the pack. Normally 8-12 pieces per day. Maxim

Adults and adolescents (12-18 years): 1 piece to be chewed when the urge to smoke is felt following the chewing technique on the pack. Normally 8-12 pieces per day. Maximum 25 pieces in 24 hours. After about 3 months the user should gradually cut down the number of pieces chewed until they have stopped using the product. Medical advice should be sought for use in adolescents beyond 12 weeks.

Users should stop smoking completely during treatment. The 1mg lozenge is for smokers of less than 20 cigarettes a day. The 2mg lozenge is for smokers of over 30 cigarett

Users should stop smoking completely during treatment. The 1mg lozenge is for smokers of less than 20 cigarettes a day. The 2mg lozenge is for smokers of over 30 cigarettes a day. For those smoking between 20-30 cigarettes a day either the 1mg or 2mg lozenge may be used depending on personal preferences and characteristics. 18 years and over: 1 lozenge to be sucked when the urge to smoke is felt following the sucking technique on the pack. Initially 1 lozenge to be taken every 1-2 hours. The usual dosage is 8-12 lozenges per day. Maximum 24 lozenges in 24 hours. Do not exceed one lozenge per hour

Relief of and/or prevention of cravings and nicotine withdrawal symptoms associated with tobacco dependence. To aid smokers wishing to quit or reduce prior to quitting. T

Relief of and/or prevention of cravings and nicotine withdrawal symptoms associated with tobacco dependence. To aid smokers wishing to quit or reduce prior to quitting. To assist smokers who are unwilling or unable to smoke, and as a safer alternative to smoking for smokers and those around them. Can be used in pregnant and lactating women making a quit attempt. Should preferably be used in conjunction with a behavioural support programme.
For smokers of more than 30 cigarettes a day. For those smoking between 20-30 cigarettes a day either the 2mg or 4mg gum may be used depending on personal preference and characteristics.

Adults and adolescents (12-18 years): 1 piece to be chewed when the urge to smoke is felt following the chewing technique on the pack. Normally 8-12 pieces per day. Maxim

Adults and adolescents (12-18 years): 1 piece to be chewed when the urge to smoke is felt following the chewing technique on the pack. Normally 8-12 pieces per day. Maximum 15 pieces in 24 hours. After about 3 months the user should gradually cut down the number of pieces chewed until they have stopped using the product. Medical advice should be sought for use in adolescents beyond 12 weeks.

Relief of and/or prevention of cravings and nicotine withdrawal symptoms associated with tobacco dependence. To aid smokers wishing to quit or reduce prior to quitting. T

Relief of and/or prevention of cravings and nicotine withdrawal symptoms associated with tobacco dependence. To aid smokers wishing to quit or reduce prior to quitting. To assist smokers who are unwilling or unable to smoke, and as a safer alternative to smoking for smokers and those around them. Can be used in pregnant and lactating women making a quit attempt. Should preferably be used in conjunction with a behavioural support programme.

Adults and adolescents (12-18 years): for those smoking 20 plus cigarettes per day, initially 1 TTS30 (step 1) patch daily. Less that 20 cigarettes per day: initially 1 T

Adults and adolescents (12-18 years): for those smoking 20 plus cigarettes per day, initially 1 TTS30 (step 1) patch daily. Less that 20 cigarettes per day: initially 1 TTS20 (step 2) patch daily. Reduce patch size at intervals of 3-4 weeks. Maximum treatment period 3 months. Medical advice should be sought for use in adolescents beyond 12 weeks. TTS 30sq cm/average absorption 21mg/24 hours. TTS20sq cm/average absorption 14mg/24 hours. TTS10sq cm/average absorption 7mg/24 hours.

Relief/prevention of craving and nicotine withdrawal symptoms associated with tobacco dependence. An aid to smokers wishing to quit or reduce prior to quitting. To assist

Relief/prevention of craving and nicotine withdrawal symptoms associated with tobacco dependence. An aid to smokers wishing to quit or reduce prior to quitting. To assist smokers unwilling or unable to smoke and as a safer alternative to smoking for smokers and those around them. Indicated in pregnant and lactating women making a quit attempt. If possible use in conjunction with behavioural support.

NiQuitin Clear 21mg (Step 1) 114mg nicotine per 22cm2
NiQuitin Clear 14mg (Step 2) 78mg nicotine per 15cm2
NiQuitin Clear 7mg (Step 3) 36mg nicotine per 7c

NiQuitin Clear 21mg (Step 1) 114mg nicotine per 22cm2
NiQuitin Clear 14mg (Step 2) 78mg nicotine per 15cm2
NiQuitin Clear 7mg (Step 3) 36mg nicotine per 7cm2

Abrupt cessation: Adult smokers 18 years or over: 10 or more cigarettes a day, start with Step 1 for 6 weeks, then continue with Step 2 for 2 weeks, then finish with Step

Abrupt cessation: Adult smokers 18 years or over: 10 or more cigarettes a day, start with Step 1 for 6 weeks, then continue with Step 2 for 2 weeks, then finish with Step 3 for 2 weeks. Less than 10 cigarettes, start with Step 2 for 6 weeks, then finish with Step 3 for 2 weeks. Treatment may be continued beyond 10 weeks if needed to stay smoke-free. However those having difficulty discontinuing patches should seek professional advice. Gradual cessation: use 21mg patch daily for 2-4 weeks and continue to smoke as needed. After 2-4 weeks quit smoking completely and use the 21mg patch for 6 weeks, then step 2 and 3 as for abrupt cessation.Reduction in smoking: use patches and continue to smoke as needed, reducing the number of cigarettes as far as possible. If using patches regularly after 6 months seek professional advice. Temporary abstinence: use patch to control withdrawal symptoms when smoking is being avoided. If using patches regularly after 6 months seek professional advice. Apply patch to clean skin site once a day, preferably on waking. Remove patch after 24 hours and apply new patch to fresh skin site. Patches may be removed before going to bed if desired. Only one patch to be worn at a time. See pack leaflet for further information. Adolescents (12-17 years): follow adult schedule for abrupt cessation. If unable to stop abruptly professional advice should be sought. Children: not recommended.

Relief/prevention of craving and nicotine withdrawal symptoms associated with tobacco dependence. An aid to smokers wishing to quit or reduce prior to quitting, to assist

Relief/prevention of craving and nicotine withdrawal symptoms associated with tobacco dependence. An aid to smokers wishing to quit or reduce prior to quitting, to assist smokers unwilling or unable to smoke or as a safer alternative to smoking. Indicated in pregnant and lactating women making a quit attempt.

18 years and over who smoke more than 20 cigarettes a day: Abrupt cessation: use the lozenges whenever there is an urge to smoke. Sufficient lozenges should be used each

18 years and over who smoke more than 20 cigarettes a day: Abrupt cessation: use the lozenges whenever there is an urge to smoke. Sufficient lozenges should be used each day, usually 8-12. Continue use for up to 6 weeks to break the habit of smoking, then gradually reduce lozenge use. When daily use is 1-2 lozenges, use should be stopped. A healthcare professional should be consulted if having difficulty discontinuing lozenges. Adolescents (12-17 years): follow schedule of treatment described for abrupt cessation. A healthcare professional should be consulted if not ready or not able to quit abruptly. Gradual cessation: use a lozenge whenever there is a strong urge to smoke in order to reduce the number of cigarettes smoked,
then start on the schedule for abrupt cessation. If reduction in cigarette consumption has not been achieved after 6 weeks a healthcare professional should be consulted. Reduction in smoking: use a lozenge whenever there is a strong urge to smoke to reduce the number of cigarettes as far as possible. Temporary abstinence: use a lozenge every 1-2 hours to control withdrawal symptoms including craving. Professional advice should be sought if unable to make a permanent quit attempt after 6 months. Maximum 15 lozenges a day. The lozenge should be moved from one side of the mouth to the other, and repeated, until the lozenge is completely dissolved (about 10 minutes). Do not chew or swallow whole. Under 12 years: not recommended.

For the treatment of tobacco dependence by relieving nicotine withdrawal symptoms including cravings associated with smoking cessation. Should be used with behavioural su

For the treatment of tobacco dependence by relieving nicotine withdrawal symptoms including cravings associated with smoking cessation. Should be used with behavioural support. NiQuitin Mint 2mg Lozenge: for those who smoke more than 30 minutes after waking. NiQuitin Mint 4mg Lozenge: for those who smoke within 30 minutes of waking.

Lozenges should be used whenever there is an urge to smoke. Adult smokers 18 years and over: weeks 1 to 6: at least 9 lozenges but no more than 15 lozenges per day. Gradu

Lozenges should be used whenever there is an urge to smoke. Adult smokers 18 years and over: weeks 1 to 6: at least 9 lozenges but no more than 15 lozenges per day. Gradually reduce use so that by week 12, 1 to 2 lozenges a day are used only on occasions when strongly tempted to smoke. A healthcare professional should be consulted if unable to make a permanent quit attempt after 6 months. Allow lozenge to dissolve in the mouth, occasionally moving lozenge from one side to the other, until dissolved (about 20-30 minutes). Do not chew or swallow whole. Adolescents (12-17 years): should use the lozenges only on the advice of a healthcare professional. Under 12 years: not recommended.

Relief and prevention of craving and nicotine withdrawal symptoms associated with tobacco dependence. An aid to smokers wishing to quit or reduce prior to quitting. To as

Relief and prevention of craving and nicotine withdrawal symptoms associated with tobacco dependence. An aid to smokers wishing to quit or reduce prior to quitting. To assist smokers unwilling or unable to smoke or as a safer alternative to smoking. Indicated in pregnant and lactating women making a quit attempt. If possible use in conjunction with behavioural support.

Adults smokers 18 years and over: for 2-4 weeks apply one patch daily and continue to smoke as needed. Once the Pre-Quit programme is completed smoking should be complete

Adults smokers 18 years and over: for 2-4 weeks apply one patch daily and continue to smoke as needed. Once the Pre-Quit programme is completed smoking should be completely stopped and the user move on to the NiQuitin step down patch programme. A healthcare professional should be consulted if the number of cigarettes smoked has not been cut down after 4 weeks of using the patches.